RWD137 Prevalence Utilization Patterns and Economic Impact of eGFR and ALK-Targeted Therapies in Non-Small Cell Lung Cancer: A Nationwide Real-World Analysis From Greece
Abstract
Authors
George Gourzoulidis Catherine Kastanioti George Mavridoglou Thodoris Kotsilieris Anastasios Tsolakidis Kostas Mathioudakis Dikaios Voudigaris Charalampos Tzanetakos